<unk>  is a radiopharmaceutical that is FDA approved for the procedure of striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian syndromes (PS).   Common adverse reactions include hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth and dizziness.
Ioflupane i-123
Phosphamidon
Technetium 
Lutetium lu 177 dotatate
Iobenguane I 123
Technetium-99m
Iopamidol
Gallium